TraceLink

Overview

TraceLink is a pharmaceutical serialization, track-and-trace, and supply-chain orchestration network for life-sciences manufacturers, CMOs, 3PLs, wholesalers, suppliers, and pharmacies. Founded in 2009 and headquartered in Wilmington, Massachusetts, the company built its initial category position around DSCSA and global serialization compliance; the current buyer-relevant scope is the OPUS / MINT stack covering partner orchestration, order-to-cash data exchange, rapid trading-partner onboarding, and agentic supply-chain workflows.

TraceLink is a multi-tenant trading-partner network and orchestration platform, not a wholesaler, specialty distributor, 3PL, or carrier. It is most relevant when the launch needs DSCSA serialization controls, EPCIS data exchange, partner connectivity, and order-to-cash visibility across an SAP or ERP environment. Compare it against ERP-native serialization modules and against point integrations when the buyer is choosing between a shared network and bespoke partner builds.

Drug Supply Chain Capability Model

The framework below standardizes how Rx Almanac evaluates drug-supply-chain capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, TraceLink is evaluated as pharmaceutical serialization, track-and-trace, and supply-chain orchestration network for life-sciences manufacturers, CMOs, 3PLs, wholesalers, suppliers, and pharmacies.

Capability	Buyer should compare	TraceLink readout
Wholesale and specialty distribution access	Wholesale scale, specialty distribution, limited distribution, provider/pharmacy reach, and trade partner relationships.	Documented as network infrastructure. TraceLink is not a wholesaler, but its value is trading-partner connectivity across manufacturers, wholesalers, 3PLs, CMOs, suppliers, and pharmacies.
3PL warehousing and order fulfillment	Warehousing, pick/pack/ship, order management, service levels, launch stocking, and direct fulfillment.	Not the use case. TraceLink is the data and orchestration layer over 3PLs; 3PL execution should be evaluated through the contracted warehouse operator.
Cold chain and specialty handling	Temperature-controlled storage, refrigerated/frozen shipping, biologics, specialty products, and excursion procedures.	Confirm complex-product handling in the RFP. OPUS supports temperature and condition-monitoring integration; confirm sensor partners, alert thresholds, and excursion-data routing for the specific lane.
DSCSA, serialization, and compliance controls	Serialization, tracing, verification, EPCIS, licensure, audit readiness, and regulatory compliance.	Core governance control. TraceLink is most directly shortlisted for DSCSA, serialization, EPCIS, track-and-trace, and regulated trading-partner data exchange across 40+ country mandates.
340B, returns, reverse logistics, or leakage controls	Returns, recalls, 340B controls, diversion monitoring, credit recovery, product destruction, and leakage management.	Adjacent. Parallel trade detection and diversion analytics live in OPUS; physical reverse logistics belongs with a 3PL or returns operator.
Inventory visibility and trade reporting	Inventory data, demand signals, EDI/API feeds, order status, channel analytics, and manufacturer reporting.	Core reporting layer. OPUS / MINT customer materials emphasize order capture, warehouse execution updates, shipment visibility, invoicing, and financial reconciliation across SAP and partner ERPs.

Buyer Fit

• Procurement trigger: Include TraceLink when the program needs DSCSA-grade serialization, EPCIS exchange, partner connectivity, and order-to-cash visibility across SAP / ERP and trading-partner environments.
• Best-fit buyers: Pharma manufacturers, biotechs, generics, and CMOs/3PLs that already have or are building multienterprise data flows with wholesalers, suppliers, and pharmacies.
• Less ideal fit: Programs whose primary need is physical channel execution, specialty pharmacy operations, or wholesale distribution should evaluate distributors and 3PLs directly; TraceLink is the data layer above them.
• Commercial fit: Subscription pricing; scope which OPUS modules, MINT connections, and onboarding services are included versus add-on, plus the data-residency and ERP-integration commitments.
• Decision checks: Confirm partner-onboarding timelines, EPCIS event coverage, ERP integration patterns (SAP ATTP, Oracle, custom), permitted AI-agent workflows, and audit / regulatory documentation.

Differentiators

• Large authenticated supply-chain network: Current company materials describe OPUS as linking 300,000+ authenticated network entities and exchanging hundreds of billions of product transactions annually.
• Mission-critical DSCSA compliance infrastructure for end-to-end drug tracing: Dominant pharmaceutical serialization and supply chain visibility platform, critical infrastructure for DSCSA compliance.
• Cloud-native, multi-tenant network architecture with powerful network effects: Shared network model designed to reduce bespoke partner integrations across manufacturers, wholesalers, 3PLs, CMOs, suppliers, and pharmacies.
• Global regulatory coverage across 40+ country serialization mandates: Serialization and track-and-trace coverage across DSCSA and other global pharmaceutical compliance regimes.
• OPUS / MINT expansion beyond compliance: Recent customer materials position MINT around order-to-cash orchestration, partner onboarding, shipment visibility, invoice reconciliation, and governed AI-agent workflows.

RFP Questions

• Which distribution role does the vendor hold, and what channel access is contractual versus partner-dependent?
• What launch stocking, allocation, shortage, and recall workflows are available?
• How are DSCSA, serialization, temperature, and license controls documented for audits?
• What inventory, order, chargeback, returns, and channel data will the manufacturer receive?
• Which wholesalers, 3PLs, CMOs, suppliers, and specialty pharmacies are already active on TraceLink for this product’s launch path?
• How will TraceLink sit alongside SAP / ERP-native track-and-trace modules, or replace a point integration layer?
• What partner onboarding time is contractually realistic, and which partner costs or setup fees are eliminated versus shifted elsewhere?

Recent Activity

• 2026-05 - Current TraceLink materials emphasize Agentic Business Network / AI Mode positioning, OPUS network counters, product taxonomy, integration formats, and LogiPharma / EPO supply-chain themes.

• 2026-05: CHEPLAPHARM began going live on TraceLink MINT, powered by OPUS, to standardize real-time data exchange between its SAP environment and global CMO and supplier ERP systems.

• 2026-04: Devatis, the U.S. affiliate of Deva Holding A.S., went live on TraceLink MINT for order-to-cash operations across wholesalers, 3PL providers, and other trading partners.

• 2025: Continued OPUS / MINT commercialization across multienterprise partner transactions, order-to-cash visibility, and agentic supply-chain workflow foundations.

• 2025: Expanded supply-chain visibility for cell and gene therapies, where chain-of-custody and chain-of-identity tracking are mandatory.

• 2024-11: DSCSA enforcement deadline reached; FDA issued temporary enforcement discretion while industry achieved full compliance.